FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Report of Foreign Private Issuer
Pursuant to Rule 13a - 16 or 15d - 16 of
the Securities Exchange Act of 1934
For the month of May, 2003
Commission File Number: 1-10817
CELLTECH GROUP PLC
(Translation of registrant's name into English)
208 Bath Road, Slough, Berkshire SL1 3WE ENGLAND
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F X Form 40-F
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes No X
(If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-________).
Enclosure: Holding(s) in Company released 27 May, 2003
SCHEDULE 10
NOTIFICATION OF MAJOR INTERESTS IN
SHARES
1. Name of company
|
Celltech Group plc |
2. Name of shareholder having a major interest
|
FMR Corp and its direct and indirect subsidiaries and Fidelity International Limited and its direct and indirect subsidiaries |
3. Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that person's spouse or children under the age of 18
|
Non-beneficial holder |
4. Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them
|
State Street Nominees Limited |
155,512 |
|
Mellon Bank |
13,418 |
|
Chase Nominees Limited |
1,862,888 |
|
State Street Bank & Trust Company |
332,200 |
|
State Street Bank & Trust |
164,700 |
|
State Street Nominees Ltd |
44,900 |
|
Lloyds Bank Nominees Limited |
197,600 |
|
Brown Brothers Harriman |
15,000 |
|
JP Morgan Chase |
91,900 |
|
Northern Trust |
33,000 |
|
MSCO |
1,252 |
|
Morgan Stanley & Co |
35,700 |
|
National Cities |
44,100 |
|
Chase Nominees |
7,977,285 |
|
Chase Manhattan Bank London |
572,600 |
|
Chase Nominees Ltd |
139,900 |
|
Citibank |
198,300 |
|
Deutsche Bank |
60,100 |
|
HSBC |
121,614 |
|
Bank of New York London |
200,200 |
|
Chase Nominees Ltd |
730,020 |
|
Northern Trust |
152,600 |
|
Credit Suisse FST BOS Zurich |
10,800 |
|
Citibank |
15,600 |
|
Chase Nominees |
1,396,500 |
|
Nortrust Nominees Ltd |
822,226 |
|
HSBC Client Holdings Nominee (UK) Ltd |
11,814,170 |
|
Chase Manhattan Bank London |
725,637 |
|
Northern Trust |
1,444,682 |
|
JP Morgan |
603,311 |
|
Bank of New York London |
1,549,100 |
|
Morgan Stanley |
349,800 |
|
Deutsche Bank |
204,600 |
|
Mellon Nominees Ltd |
36,900 |
|
State Street Nominees Ltd |
248,900 |
|
Bank of New York Brussels |
516,741 |
|
State Street Bank & Trust |
623,372 |
|
HSBC |
100,900 |
|
National Australia Bank |
12,000 |
|
PICG |
6,200 |
|
Chase Manhattan Bank AG Frankfurt |
30,100 |
|
Citibank |
18,800 |
|
HSBC Client Holdings Nominee (UK) Ltd |
200 |
5. Number of shares / amount of stock acquired
|
1,280,701 since last notification |
6. Percentage of issued class
|
0.46% |
7. Number of shares / amount of stock disposed
|
N/a |
8. Percentage of issued class
|
N/a |
9. Class of security
|
Ordinary 50p Shares |
10. Date of transaction
|
23 May 2003 |
11. Date company informed
|
27 May 2003 |
12. Total holding following this notification
|
33,675,328 |
13. Total percentage holding of issued class following this notification
|
12.13% |
14. Any additional information
|
- |
15. Name of contact and telephone number for queries
|
Anita Dowling (01753) 777106 |
16. Name and signature of authorised company official responsible for making this notification
|
J A D Slater |
Date of notification
|
27 May 2003 |
The FSA does not give any express or implied warranty as to the accuracy of this document or material and does not accept any liability for error or omission. The FSA is not liable for any damages (including, without limitation, damages for loss of business or loss of profits) arising in contract, tort or otherwise from the use of or inability to use this document, or any material contained in it, or from any action or decision taken as a result of using this document or any such material.
END
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
CELLTECH
GROUP PLC
(Registrant)
By: /s/
PETER ALLEN
Peter
Allen
Chief
Financial Officer
Dated: 27 May, 2003